Vapourtec Expands R-Series Capabilities
News Nov 19, 2014
The R2-S pump module is a special self priming, suspension / slurry capable version that is ideal for organometallic reagents, metering gases and strong acids such as fuming Nitric Acid and can be added to an existing two pump arrangement to deliver enhanced capability.
Vapourtec MD Duncan Guthrie commented: "At the heart of the R2-S is our V-3 precision peristaltic pump which features advanced control and is capable of handling strong acids, bases and organometallic reagents as well as a range of gases and generates a smooth output flow across the full pressure range.
"Nearly 200 of the V-3 pumps are in daily use in labs around the world and its capability to pump organometallic reagents has been well documented in peer reviewed publications.
"We launched the R-Series in 2007 and it has since gone on to become one of the world's leading flow chemistry systems. The addition of the R2-S pump module significantly increases the potential of the R-Series," added Duncan.
Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors across the globe including education, pharmaceutical and industry and their technology has been cited in over 125 published papers as playing a pivotal part in recent major research breakthroughs.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Improving Pharmaceuticals: Catalyst Specifically Tuned to Integrate Fluorine AtomsNews
In the race to create more potent and stable medicines, scientists know that adding fluorine can improve drug molecules. However, there is only one fluorination reaction known to occur in nature which is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018